-
1.
公开(公告)号:US20110114517A1
公开(公告)日:2011-05-19
申请号:US12948195
申请日:2010-11-17
申请人: Kasey Jon Minick , Manal M. Gabriel , Leroy Wainaina Muya , Walter Lee Nash , George Edward Minno
发明人: Kasey Jon Minick , Manal M. Gabriel , Leroy Wainaina Muya , Walter Lee Nash , George Edward Minno
CPC分类号: A01N59/00 , A61L12/128
摘要: The present invention relates to a hydrogen peroxide solution for disinfecting contact lenses. The hydrogen peroxide solution contains an effective amount of a homopolymer or copolymer of vinylpyrrolidone to an increased residual hydrogen peroxide concentration when in the presence of a catalyst, thereby prolonging the effective life of the solution and providing greater comfort to the weather. The present invention also relates to a kit for use in the disinfection of contact lenses comprising: a) an aqueous hydrogen peroxide solution, wherein the aqueous hydrogen peroxide solution comprising a homopolymer or copolymer of vinylpyrrolidone and an effectively disinfecting amount of hydrogen peroxide, and b) a container for holding a given amount of hydrogen peroxide solution, wherein the container containing a disc, wherein the disc comprising a substrate and a catalyst coating thereon, wherein, when the given amount of hydrogen peroxide is added to the container to entirely submerge the catalyst coated disc, the aqueous hydrogen peroxide solution decomposes over a period time of six hours to provide a residual hydrogen peroxide concentration of less than 100 ppm.
摘要翻译: 本发明涉及一种用于消毒隐形眼镜的过氧化氢溶液。 当存在催化剂时,过氧化氢溶液含有有效量的乙烯基吡咯烷酮的均聚物或共聚物与增加的剩余过氧化氢浓度,从而延长溶液的有效寿命并为天气提供更大的舒适度。 本发明还涉及一种用于隐形眼镜消毒的试剂盒,包括:a)过氧化氢水溶液,其中包含乙烯基吡咯烷酮的均聚物或共聚物和有效消毒量的过氧化氢的过氧化氢水溶液和b )用于保持给定量的过氧化氢溶液的容器,其中所述容器包含盘,其中所述盘包括基底和其上的催化剂涂层,其中当将给定量的过氧化氢加入到容器中以完全浸没 催化剂涂覆的圆盘,过氧化氢水溶液在六小时的时间段内分解,以提供小于100ppm的残余过氧化氢浓度。
-
公开(公告)号:US20090057164A1
公开(公告)日:2009-03-05
申请号:US12229771
申请日:2008-08-27
CPC分类号: B65B25/008 , A61L12/04 , G02B1/043
摘要: The present invention relates to improved contact lens products which not only have initial insertion comfort. The contact lens product of the invention comprises a soft hydrogel contact lens immersed and autoclaved in a packaging solution including a low molecular weight polyethylene glycol (PEG) (or glycerin) and a homopolymer or copolymer of vinylpyrrolidone. The present invention also provides methods for making contact lens products of the invention.
摘要翻译: 本发明涉及不仅具有初始插入舒适性的改进的隐形眼镜产品。 本发明的隐形眼镜产品包括在包含低分子量聚乙二醇(PEG)(或甘油)和乙烯基吡咯烷酮的均聚物或共聚物的包装溶液中浸泡并高压灭菌的软水凝胶隐形眼镜。 本发明还提供了制造本发明隐形眼镜产品的方法。
-
公开(公告)号:US08689971B2
公开(公告)日:2014-04-08
申请号:US12229771
申请日:2008-08-27
CPC分类号: B65B25/008 , A61L12/04 , G02B1/043
摘要: The present invention relates to improved contact lens products which not only have initial insertion comfort. The contact lens product of the invention comprises a soft hydrogel contact lens immersed and autoclaved in a packaging solution including a low molecular weight polyethylene glycol (PEG) (or glycerin) and a homopolymer or copolymer of vinylpyrrolidone. The present invention also provides methods for making contact lens products of the invention.
摘要翻译: 本发明涉及不仅具有初始插入舒适性的改进的隐形眼镜产品。 本发明的隐形眼镜产品包括在包含低分子量聚乙二醇(PEG)(或甘油)和乙烯基吡咯烷酮的均聚物或共聚物的包装溶液中浸泡并高压灭菌的软水凝胶隐形眼镜。 本发明还提供了制造本发明隐形眼镜产品的方法。
-
4.
公开(公告)号:US06261546B1
公开(公告)日:2001-07-17
申请号:US09301895
申请日:1999-04-29
申请人: Fu-Pao Tsao , George Edward Minno
发明人: Fu-Pao Tsao , George Edward Minno
IPC分类号: A61K3174
CPC分类号: A61K47/02 , A61K9/0048 , A61K31/221 , A61K47/12
摘要: A pharmaceutical product which includes two-chambers, one having a buffered diluent and the other having acetylcholine. Upon mixing the chamber contents, a buffered efficacious acetylcholine product is prepared for post-surgical ophthlamic injection. Another embodiment of the invention is a method of providing an acetylcholine product which has a substantially consistent final pH without substantial degradation of the acetylcholine. The method involves storing an unbuffered acetylcholine separate from a diluent solution which has been buffered, and mixing prior to use.
摘要翻译: 一种药物产品,其包括两室,一个具有缓冲稀释剂,另一个具有乙酰胆碱。 在混合室内容物后,制备缓冲的有效的乙酰胆碱产品用于手术后玻璃体注射。 本发明的另一个实施方案是提供乙酰胆碱产物的方法,其具有基本上一致的最终pH而不显着降解乙酰胆碱。 该方法包括将未缓冲的乙酰胆碱与已缓冲的稀释溶液分开并在使用前进行混合。
-
-
-